As of Apr 27
| -0.10 / -1.24%|
The 4 analysts offering 12-month price forecasts for Derma Sciences Inc have a median target of 16.50, with a high estimate of 18.00 and a low estimate of 9.00. The median estimate represents a +106.51% increase from the last price of 7.99.
The current consensus among 4 polled investment analysts is to Buy stock in Derma Sciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.